- Title
- Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers
- Creators
- Jan Lubiński (Author) - Pomeranian Medical University in SzczecinHenry T. Lynch (Author) - Department of Preventive MedicineRita Schmutzler (Author) - University of CologneMonique M.A. Brood-Van Zanten (Author) - Vrije Universiteit AmsterdamMarius J. Van Der Mooren (Author) - Vrije Universiteit AmsterdamRené H.M. Verheijen (Author) - Vrije Universiteit AmsterdamPeter Kenemans (Author) - Vrije Universiteit AmsterdamTracy Dudding (Author) - University of NewcastleJudy Kirk (Author) - Westmead HospitalShirley Hodgson (Author) - St. George's University of LondonLenka Foretova (Author) - Masaryk Memorial Cancer InstituteBarbara Weber (Author) - GlaxoSmithKlineTimothy R. Rebbeck (Author) - University of PennsylvaniaJill E. Stopfer (Author) - University of PennsylvaniaSusan Domchek (Author) - University of Pennsylvania
- Additional links
- Anon
- Publication Details
- Hereditary Cancer in Clinical Practice, Vol.3(3), pp.87-91
- Series
- 3
- Number of pages
- 5
- Identifiers
- 991005930623402656
- Academic Unit
- Prev. Medicine & Public Health
- Language
- English
- Resource Type
- Annotation
Annotation
Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers
Hereditary Cancer in Clinical Practice, Vol.3(3), pp.87-91
3
2005
Related links
Metrics
4 Record Views